Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster session 08

2278P - Endothelial cell heterogeneity defined by single-cell spatial transcriptomic analysis of breast cancers

Date

21 Oct 2023

Session

Poster session 08

Topics

Cancer Biology;  Tumour Immunology;  Pathology/Molecular Biology;  Translational Research

Tumour Site

Breast Cancer

Presenters

Krisztian Homicsko

Citation

Annals of Oncology (2023) 34 (suppl_2): S1152-S1189. 10.1016/S0923-7534(23)01927-0

Authors

K. Homicsko1, K. Zaman2, A. Stravodimou3

Author affiliations

  • 1 Oncology Department, CHUV - Centre Hospitalier Universitaire Vaudois, 1005 - Lausanne/CH
  • 2 Oncology Dept., CHUV - Centre Hospitalier Universitaire Vaudois, 1011 - Lausanne/CH
  • 3 Medical Oncology Department, CHUV - Centre Hospitalier Universitaire Vaudois, 1011 - Lausanne/CH

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Abstract 2278P

Background

The heterogeneity of the tumor microenvironment is a major barrier for effective cancer therapies. Similar to the immune tumor microenvironment the stromal environment, composed of cancer-associated fibroblasts (CAFs), pericytes, adipocytes and endothelial cells, is also heterogeneous. Multiple studies showed that CAFs contain heterogenous cell populations with opposing pro and anti-tumoral function. The heterogeneity of endothelial cells (ECs) is less well described largely due to the relative low frequencies in tumor tissues compare to CAFs. We set out to study the heterogeneity of the tumor microenvironment using truly single-cell spatial transcriptomic by the 10x Genomics Xenium platform.

Methods

We analyzed 20 human breast tumors by Xenium single-cell analyzes using fluorescent in situ sequencing (FISSEQ). We used the available breast panel that contains 280 genes, with 8 probes for each gene. The analysis of the data was preformed using the Seurat pipeline in R (version 4.9.9.9039).

Results

We could readily identify blood vessel structures that surrounded PECAM1/VWF positive cells. After multiple clustering we identified five types of endothelial cells with divergent gene expression profiles. We defined the following clusters of ECs: 1) Proliferating ECs, 2) CXCL12+ ECs, 3) POSTNHi/VWFHi ECs, 4) TPD52Hi ECs and POSTNLow/VWFHi ECs. The endothelial cells also showed spatial variations in distribution. Data on EC subtypes will correlation and other cell types and cell neighborhoods will be presented.

Conclusions

ECs in breast cancer tumors are highly heterogeneous and can be further classified into functionally divergent subtypes, potentially contributing to the heterogenous responses observed to treatments.

Clinical trial identification

Editorial acknowledgement

Legal entity responsible for the study

CHUV.

Funding

CHUV.

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.